NASDAQ:ZVRA – Knox Daily

Stock Earnings

Zevra Therapeutics Inc’s recent filing unveils that its Director Watton Corey Michael acquired Company’s shares for reported $3958.0 on Oct

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zevra Therapeutics

Analysts Viewpoint

Zevra Therapeutics Inc’s filing revealed that its Director Watton Corey Michael acquired Company’s shares for reported $3958.0 on Oct 11

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Zevra Therapeutics Inc’s recent filing unveils that its Director Watton Corey Michael acquired Company’s shares for reported $3958.0 on Oct

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Zevra Therapeutics Inc’s filing revealed that its Director Watton Corey Michael acquired Company’s shares for reported $3958.0 on Oct 11

Stock Earnings

Zevra Therapeutics Inc’s recently made public that its Director Watton Corey Michael acquired Company’s shares for reported $3958.0 on Oct

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: NASDAQ:ZVRA